Vaccines are one of the most effective public health interventions ever developed. They protect millions of people worldwide from life-threatening infectious diseases by stimulating the body’s immune system to produce active immunity. Within primary healthcare settings, nurses play a pivotal role in administering, managing, and educating patients about essential vaccines included in universal immunization programs.
Table of Contents
- What are vaccines and how do they work?
- Types of vaccine preparations
- BCG vaccine for tuberculosis
- Administration and dosage
- Normal reaction and side effects
- Storage requirements
- DPT vaccine for diphtheria, pertussis, and tetanus
- Vaccination schedule
- Contraindications and side effects
- DT vaccine for diphtheria and tetanus
- Measles vaccine
- Administration and side effects
- Storage considerations
- Poliomyelitis vaccine
- Dosage and schedule
- Tetanus toxoid for pregnant women
- Administration schedule
- Vaccine storage: the cold chain
- Key storage principles
- Patient education and compliance
What are vaccines and how do they work?
Vaccines work by introducing a weakened, killed, or partial form of a pathogen into the body, prompting the immune system to recognize and remember it. When exposed to the actual disease later, the body can mount a rapid and effective defense. The World Health Organization’s Expanded Programme on Immunization (EPI), launched in 1974, initially focused on protecting children against six vaccine-preventable diseases. Today, national immunization programs cover more than a dozen diseases, significantly reducing childhood morbidity and mortality.
Types of vaccine preparations
Vaccines are prepared using different methods depending on the disease they target. Live attenuated vaccines contain weakened forms of the microorganism that can replicate but do not cause disease in healthy individuals. Killed (inactivated) vaccines use pathogens that have been destroyed through heat or chemicals. Toxoid vaccines are made from inactivated toxins produced by bacteria. Combination vaccines protect against multiple diseases in a single formulation, reducing the number of injections required.
BCG vaccine for tuberculosis
Bacillus Calmette-Guérin (BCG) is the only licensed vaccine against tuberculosis and remains one of the most widely administered vaccines globally. Developed in 1921, BCG contains a live attenuated strain of Mycobacterium bovis. It is typically part of routine newborn immunization schedules in countries where TB is common.
Administration and dosage
BCG vaccine is administered as a single intradermal injection, usually in the deltoid region of the upper arm. The standard dose is 0.05 ml for infants under one year and 0.1 ml for older children and adults. In countries where tuberculosis is common, the vaccine is given to healthy babies as soon after birth as possible. The intradermal injection causes a characteristic skin reaction that develops over several weeks.
Normal reaction and side effects
After vaccination, a small papule appears at the injection site within two to four weeks. This develops into an ulcer that usually heals spontaneously over several months, leaving a permanent scar. Mild side effects may include local swelling and tenderness. Rare complications include persistent ulceration, non-suppurative lymphadenitis, and, exceptionally, suppurative lymphadenitis or osteitis.
Storage requirements
BCG vaccine must be stored between 2°C and 8°C and protected from light. It should never be frozen. After reconstitution, the vaccine should be used within eight hours and stored in a refrigerator. The diluent must also be refrigerated before use to ensure both components are at the same temperature during reconstitution.
DPT vaccine for diphtheria, pertussis, and tetanus
The DPT vaccine is a combination vaccine that protects against three serious bacterial infections. It contains diphtheria and tetanus toxoids along with either whole-cell (DTwP) or acellular (DTaP) pertussis components. The vaccine has been instrumental in dramatically reducing cases of these potentially fatal diseases.
Vaccination schedule
Primary vaccination consists of three doses given four weeks apart, preferably before six months of age. The recommended schedule is at 6 weeks, 10 weeks, and 14 weeks of age. A booster dose is given between 12 and 23 months. In many countries, an additional booster is administered at school entry (4-6 years). Each dose is 0.5 ml administered intramuscularly into the anterolateral thigh for children under two years or the deltoid muscle for older children.
Contraindications and side effects
DPT should not be given to children who have had severe allergic reactions to a previous dose or those with evolving neurological disease. Common side effects include mild local reactions such as redness and pain at the injection site, low-grade fever, and irritability. Severe reactions are rare but may include high fever, persistent crying, and seizures. If a child experiences severe neurological symptoms after vaccination, further pertussis-containing vaccines should be avoided.
DT vaccine for diphtheria and tetanus
The DT vaccine is used when pertussis vaccination is contraindicated. It contains diphtheria and tetanus toxoids only. The dose is 0.5 ml administered by deep intramuscular injection. This vaccine follows the same schedule as DPT when used as a substitute and is stored between 2°C and 8°C.
Measles vaccine
Measles remains a leading cause of vaccine-preventable deaths worldwide, particularly in young children. The measles vaccine contains live attenuated virus and is often combined with mumps and rubella vaccines as MMR or with rubella alone as MR. The first dose is typically administered at 12 to 15 months of age, with a second dose at 4 to 6 years.
Administration and side effects
The vaccine is given as a 0.5 ml dose via subcutaneous or intramuscular injection. Common side effects include mild fever and rash occurring 7-12 days after vaccination. Febrile seizures occur rarely. The vaccine is contraindicated in pregnant women, severely immunocompromised individuals, and those with history of anaphylaxis to vaccine components.
Storage considerations
Measles vaccine must be protected from light, which can inactivate the vaccine viruses. It should be stored frozen between -25°C and -15°C or refrigerated between 2°C and 8°C depending on the formulation. The diluent can be stored at refrigerator temperature or room temperature but should never be frozen.
Poliomyelitis vaccine
Two types of polio vaccines exist: inactivated polio vaccine (IPV) given by injection and oral polio vaccine (OPV) given as drops. OPV contains live attenuated virus and was historically the primary vaccine used in eradication efforts due to its ease of administration and ability to induce intestinal immunity. IPV contains killed virus and is safer, eliminating the rare risk of vaccine-associated paralytic polio.
Dosage and schedule
IPV produces immunity in over 95% of recipients after three doses. The routine schedule includes doses at 2, 4, and 6-18 months, with a booster at 4-6 years. OPV is given as 2 drops per dose at similar intervals. Many countries now use a combined approach with IPV followed by OPV. OPV must be stored frozen at -20°C, while IPV is stored at 2°C to 8°C and must never be frozen.
Tetanus toxoid for pregnant women
Tetanus toxoid (TT) vaccination of pregnant women is essential for preventing maternal and neonatal tetanus. The WHO recommends a schedule of five doses throughout a woman’s reproductive years to ensure long-term protection. For women who have never been vaccinated, two doses are administered during the first pregnancy, with subsequent doses in following pregnancies.
Administration schedule
The recommended schedule for previously unvaccinated pregnant women is three doses at 0, 4 weeks, and 6-12 months. The vaccine should preferably be given between 27 and 36 weeks of gestation to maximize antibody transfer to the infant. Each dose is 0.5 ml administered intramuscularly in the upper arm. Side effects are usually mild, including local pain and swelling at the injection site.
Vaccine storage: the cold chain
Maintaining proper storage conditions is critical for vaccine efficacy. The standard cold chain temperature for most vaccines is 2°C to 8°C. Exposure to temperatures outside this range can reduce potency or render vaccines ineffective. Some vaccines, like OPV and MMR, require frozen storage, while others like DPT are damaged by freezing.
Key storage principles
Vaccines should be stored in dedicated pharmaceutical-grade refrigerators with continuous temperature monitoring. They must be placed away from walls, vents, and doors to avoid temperature fluctuations. All vaccines should be clearly labeled with expiration dates and protected from light. Reconstituted vaccines must be used within the specified timeframe. A written storage and handling plan should be maintained, including emergency procedures for equipment failures.
Patient education and compliance
Effective vaccine management extends beyond proper storage and administration. Healthcare providers must educate patients and caregivers about the importance of completing vaccination schedules, expected side effects, and signs that require medical attention. Clear communication builds trust and improves compliance with immunization programs.
What do you think? How can healthcare facilities in resource-limited settings better maintain the cold chain to ensure vaccine efficacy? What strategies have you found effective in addressing vaccine hesitancy among parents?
References
- https://www.paho.org/en/topics/immunization
- https://www.ncbi.nlm.nih.gov/books/NBK538185/
- https://www.cdc.gov/tb/hcp/vaccines/index.html
- https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-2-bacille-calmette-guerin-vaccine.html
- https://www.ncbi.nlm.nih.gov/books/NBK545173/
- https://medicalguidelines.msf.org/en/viewport/EssDr/english/diphteria-tetanus-pertussis-vaccine-dtp-16688268.html
- https://www.paho.org/en/diphtheria-tetanus-and-pertussis-dtp-vaccine
- https://www.merckvaccines.com/mmr/storage-handling/
- https://www.cdc.gov/vaccines/vpd/mmr/hcp/storage-handling.html
- https://en.wikipedia.org/wiki/Polio_vaccine
- https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-17-poliomyelitis-vaccine.html
- https://www.who.int/initiatives/maternal-and-neonatal-tetanus-elimination-(mnte)/the-strategies
- https://www.cdc.gov/vaccines-pregnancy/hcp/vaccination-guidelines/index.html
- https://en.wikipedia.org/wiki/Vaccine_storage
- https://www.news-medical.net/health/How-are-Vaccines-stored.aspx
Leave a Reply